Senate Committee on Health, Education, Labor, and Pensions

National Plan for Epilepsy Act

National Plan for Epilepsy Act This bill requires the Department of Health and Human Services (HHS) to establish a national plan, form an advisory council, and take other actions to address epilepsy. The requirements sunset on December 31, 2035. Specifically, the bill requires HHS to carry out a National Plan for Epilepsy to prevent, diagnose, treat, and cure epilepsy. In carrying out the plan, HHS must implement activities such as coordinating research and services across all federal agencies and soliciting public comments. Also, HHS must establish an Advisory Council on Epilepsy Research, Care, and Services. The advisory council must report to HHS and Congress every two years with an evaluation of federally funded efforts. Additionally, HHS must annually report to Congress with recommended actions based on its assessments of the nation’s progress on epilepsy.

Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026

Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026 This bill reauthorizes through FY2031 and revises programs that support research and development of drugs and other therapies to address amyotrophic lateral sclerosis (also known as ALS or Lou Gehrig's disease) and other neurodegenerative diseases. The bill reauthorizes grants from the National Institutes of Health (NIH) for scientific research on investigational drugs to prevent or treat ALS for individuals not otherwise eligible for clinical trials, grants from the Food and Drug Administration (FDA) for research and development of therapies to prevent and treat ALS and other neurodegenerative diseases, and a Public-Private Partnership including the FDA and NIH that supports development and regulatory review of treatments for neurodegenerative diseases. Also, the bill revises the NIH grants to require (1) the NIH, in considering grant renewal, to assess available information on the safety and efficacy of the investigational drugs; (2) grantees to promptly report available safety data from ongoing clinical trials; and (3) the NIH to determine the timeframe for enrollment in clinical trials for the investigational drugs. Additionally, every five years, the FDA must publish a plan describing actions it will take over a five-year period to foster development of safe and effective drugs, and facilitate access to investigational drugs, for ALS and other rare neurodegenerative diseases. Each plan must include the FDA's previous actions and recommendations for improvements. Finally, the Government Accountability Office and the Department of Health and Human Services must report on the impacts of these grants.

Kay Hagan Tick Reauthorization Act

The legislation reauthorizes federal funding and programs focused on preventing and treating tick-borne diseases like Lyme disease. It would support research, education, and public health efforts to help reduce the spread of these illnesses that affect millions of Americans each year. The bill impacts public health agencies, researchers, and communities dealing with tick-borne disease outbreaks.

DeOndra Dixon INCLUDE Project Act of 2026

A resolution celebrating the 80th anniversary of the Centers for Disease Control and Prevention, the premier public health institute of the United States.

A resolution expressing recognition and appreciation for the contributions of hotel employees and supporting the goals and ideals of National Hotel Employee Day.

Rural Mothers and Fathers Choice Act

Community Mental Wellness Worker Training Act

INSULIN Act of 2026

This bill would likely work to make insulin more affordable and accessible for Americans with diabetes by addressing high drug prices through measures such as capping out-of-pocket costs, increasing transparency in pricing, or expanding insurance coverage. The changes would primarily affect diabetic patients who struggle to afford their medication, as well as insurance companies and pharmaceutical manufacturers that produce insulin. The bill is currently under review by the Senate committee responsible for health policy.

Momnibus Act

Constructing the Path to Suicide Prevention Act

PROTECT Act

INSPIRES Act

Summer Meals and Learning Act of 2026

Summer Meals and Learning Act of 2026 This bill establishes a grant program to support summer early reading programs held at schools with a summer lunch site. Specifically, the Department of Education must use funds provided for the program to award competitive grants to state library administrative agencies to enable them to award subgrants to eligible local educational agencies for summer early reading programs held at schools with a summer lunch site. The program is open to local educational agencies that include schools where at least 50% of the students in prekindergarten through grade 3 are (1) reading below grade level at grade 3, or (2) at risk of reading below grade level at grade 3.

Fairness for Farm Workers Act

Guaranteed Paid Vacation Act

GREEN Hospitals Act

READ Act

The bill would improve how schools teach reading by requiring states to use teaching methods backed by scientific research about how people learn to read. It would provide federal funding and support for teacher training programs, research into effective reading instruction, and accountability measures to track whether students are actually improving their reading skills. The changes would affect students, teachers, and school districts across the country.

NIH Mentorship Modernization Act

Colorectal Cancer Early Detection Act